UC San Diego Health announces it has been recognized as a top performer in the 2021 Bernard A. Birnbaum, MD, Quality Leadership Annual Ranking by Vizient Inc.
UC San Diego researchers report that conducting genomic evaluations of advanced malignancies can be effective in guiding first-line-of-treatment, rather than waiting until standard-of-care therapies have failed.
Molecular profiling is more often used after standard cancer treatments have failed, but a new study suggests that it could effectively guide first-line treatment, especially for poor-prognosis cancers
Kurt Schaberg, an assistant professor in Pathology and Laboratory Medicine, has been named one of the Top Six of the American Society for Clinical Pathology’s 40 under Forty honorees for 2021. Schaberg’s educational pathology website, Kurt’s Notes, has followers from 147 countries.
A team of UCSF scientists have identified the specific neurons and signaling pathway that make sexually receptive females of many species more active at the time of ovulation.
